Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Sodium Divalproate 500 mg
NCT03914534Phase 4Completed
- Sponsor
- Tecnoquímicas S.A.
- Start
- Apr 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of divalproex sodium in epilepsy, sponsored by Tecnoquímicas S.A.. Started Apr 2017; status: completed.
02
Drugs
divalproex sodium
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03914534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03914534.